Oxygenta Pharmaceutical opened higher at ₹50.00, compared with its previous close of ₹48.45. During today's session, the stock has traded between ₹50.00 and ₹50.79, with an average traded price of ₹50.75. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Oxygenta Pharmaceutical is now worth
₹ 14,243.00
Giving a profit of
₹ 4,243.00 (42.43%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+2.33 (+4.81%)
Day High
₹50.79
Day Low
₹50.00
Day Open
₹50.00
Prev Close
₹48.45
Volume
5,493
Value Traded
₹0.03 Cr
1W Return
4.81%
1M Return
4.70%
3M Return
-25.19%
6M Return
-7.92%
1Y Return
-20.28%
Market Cap (₹ Cr.)
188
PE Ratio
-15.70
PB Ratio
-3.80
Dividend Yield
-
ROE
41.16%
ROCE
-51.82%
Book Value (₹)
-12.74
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
4.81%
6 Weeks
-
1 Month
4.70%
3 Months
-25.19%
9 Months
-12.45%
No data available.
Oxygenta Pharma Q2FY27 loss narrows to ₹273.53 lakh on revenue surge
Net loss narrowed to ₹273.53 lakh in Q2FY27 from ₹493.04 lakh in Q2FY26. Revenue from operations jumped 134% YoY to ₹3,349.39 lakh. Finance costs tripled to ₹273.02 lakh, impacting profitability. Operating cash flow turned positive at ₹535.02 lakh for H1FY27.
2 days agoOxygenta Pharma acquires land in Telangana for ₹6.75 crore
Oxygenta Pharmaceutical acquired 36,421 sq mtr land in Telangana. Total consideration for the plot is ₹6.75 crore. Allotment letter issued by TGIIC on October 1, 2026. Acquisition aims to support long-term business expansion.
1mo agoOxygenta Pharma shareholders approve all seven AGM resolutions
Oxygenta Pharmaceutical shareholders approved all seven AGM resolutions on August 21, 2026. Total voting turnout was 12.09%, with promoters holding 20.9 million shares abstaining from voting. Related-party transactions with holding company Virupaksha Organics received highest dissent at 109 votes against. New appointments include Whole-time Director A.V. Reddy and Independent Director J.R. Yeddula.
2mo agoOxygenta Pharmaceutical sets Aug 15-21 book closure for 33rd AGM
Oxygenta Pharmaceutical Limited will close its books from August 15 to August 21, 2026, for its 33rd AGM. The remote e-voting cut-off is set for August 14, 2026. The meeting will be conducted via video conference on August 21.
3mo agoOxygenta Pharma seeks approval for ₹450 crore RPTs at AGM
Oxygenta Pharmaceutical seeks shareholder approval for ₹450 crore in commercial and financial related party transactions with its holding company, Virupaksha Organics Limited, at its upcoming AGM. The company reported a net loss of ₹1,757.17 lakhs for FY 2025-26 and faces going concern risks due to negative equity.
3mo agoOxygenta Pharmaceutical net loss narrows 66% as revenue surges 144% in Q1FY27
Oxygenta Pharmaceutical Limited posted a Q1FY27 net loss of ₹2.10 crore, a 66% improvement from the previous year, fueled by a 144% revenue surge to ₹36.99 crore. Despite higher expenses and finance costs from ECLGS borrowings, the company narrowed its loss significantly. The Board also appointed PCR & Associates as Cost Auditors and reconstituted the POSH Committee.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,899.30 | +0.76% | ₹4,55,705.69 | 41.20 | +9.65% | |
| ₹11,495.00 | +0.09% | ₹3,05,156.13 | 90.40 | +76.30% | |
| ₹4,685.20 | -0.89% | ₹1,78,209.95 | 85.50 | +22.50% | |
| ₹2,427.00 | +1.13% | ₹1,31,133.78 | 97.10 | +145.34% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.30 | +0.12% | ₹1,15,878.66 | 42.00 | +12.91% | |
| ₹1,409.80 | +0.11% | ₹1,13,891.88 | 39.90 | -7.21% | |
| ₹2,663.30 | +0.94% | ₹1,10,006.30 | 48.10 | +17.33% | |
| ₹1,808.90 | +0.09% | ₹1,04,080.11 | 26.00 | +52.83% | |
| ₹2,019.10 | +0.20% | ₹92,331.42 | 17.60 | -0.73% | |
| ₹2,639.00 | -0.78% | ₹74,479.09 | 51.60 | +42.82% | |
| ₹5,194.00 | -2.04% | ₹62,102.06 | 30.50 | -9.94% |
An investment of ₹10,000 made 5 years ago in Oxygenta Pharmaceutical is now worth
₹ 14,243.00
Giving a profit of
₹ 4,243.00 (42.43%)
Note: Past profits do not guarantee future returns.
